← Back to Search

Radiation Therapy

1 for Anal Cancer

Phase 2
Waitlist Available
Led By Kurian J Joseph, MD, FRCPC
Research Sponsored by AHS Cancer Control Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 and 5 years
Awards & highlights

Study Summary

The hypothesis is that helical tomotherapy could minimize radiation related toxicity by avoiding or limiting doses to structures such as small bowel, external genitalia, skin, bladder, rectum, and femoral neck and head.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 and 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acute Toxicity and Quality of LIfe
Secondary outcome measures
Local Recurrence
colostomy-free survival and/or overall survival

Trial Design

1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
anal cancer patients treated with tomotherapy and chemotherapy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tomotherapy
2013
Completed Phase 2
~140

Find a Location

Who is running the clinical trial?

AHS Cancer Control AlbertaLead Sponsor
182 Previous Clinical Trials
36,154 Total Patients Enrolled
Kurian J Joseph, MD, FRCPCPrincipal InvestigatorAHS Cancer Control Alberta

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Receiving Chemotherapy and Radiation Using Helical Tomotherapy
2008. "A Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Receiving Chemotherapy and Radiation Using Helical Tomotherapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00754078.
All > Toxicity
~3 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top